Genome-wide association study reveals genetic risk underlying Parkinson's diseaseCan Zipf's law be adapted to normalize microarrays?The treatment of tremorTime to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.Post-partum cerebral angiopathy: repetitive TCD, MRI, MRA, and EEG examinationsMyoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotypeNeuronal Networks during Burst Suppression as Revealed by Source AnalysisPolymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremorKnowledge gaps and research recommendations for essential tremor.Transducer-based evaluation of tremor.Dynamic imaging of coherent sources reveals different network connectivity underlying the generation and perpetuation of epileptic seizuresPalatal tremor: the clinical spectrum and physiology of a rhythmic movement disorder.Beamformer source analysis and connectivity on concurrent EEG and MEG data during voluntary movements.Multi-modal causality analysis of eyes-open and eyes-closed data from simultaneously recorded EEG and MEG.Deep brain stimulation: postoperative issues.Falls in frequent neurological diseases--prevalence, risk factors and aetiology.Patients with Parkinson's disease learn to control complex systems-an indication for intact implicit cognitive skill learning.Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyTransient global amnesia: functional anatomy and clinical implications.Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.Associative stimulation of the supraorbital nerve fails to induce timing-specific plasticity in the human blink reflex.Rivastigmine for dementia associated with Parkinson's disease.Treatment of patients with essential tremor.Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample.Motor re-training does not need to be task specific to improve writer's crampDopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients.Source analysis of beta-synchronisation and cortico-muscular coherence after movement termination based on high resolution electroencephalography.Expression pattern and localization of alpha-synuclein in the human enteric nervous system.MDS clinical diagnostic criteria for Parkinson's disease.MDS research criteria for prodromal Parkinson's disease.Clinical spectrum and physiology of palatal tremor.Transient filament occlusion of the middle cerebral artery in rats: does the reperfusion method matter 24 hours after perfusion?Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.Pallidal deep-brain stimulation in primary generalized or segmental dystonia.Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.Pathophysiology of nonparkinsonian tremors.Deep brain stimulation for tremor [correction of trauma]: patient selection and evaluation.Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.Increased volume and impaired function: the role of the basal ganglia in writer's cramp.Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease.
P50
Q24646654-2391BBD1-2ABE-4E61-A314-A6CCE16CB6C9Q24803254-F918A575-1A9C-4FE0-8605-8795DF481624Q27022935-2861B8FC-5CE5-4830-A05B-24037A1C48F5Q27686808-4F3797D7-8BE0-46FC-9B08-3C7890E4342AQ28193786-9F918CC3-BF0C-4576-9D45-1932DCE9E310Q28204029-21F43A10-4A66-495C-A568-DDF3F92AEEACQ28546861-A771FD8D-B997-417B-932D-FF661D39BB74Q28943371-AFA15A96-C6BE-4B92-BD0E-DAF0E86BD61CQ30244228-4490F473-D5BD-4BE8-9200-2F7600B4C4CEQ30249764-251908EC-372C-4CB3-80F3-2F6E93109F8BQ30553135-589CBF75-7867-4143-930D-9419EA93D35FQ30689225-2215065B-67B8-4AF3-81AC-5706E423F541Q30775234-ED07104F-A1ED-4279-BEDB-9F52B455A827Q30883409-98F3B05C-8D2B-404F-BD1C-C030D1014999Q31047638-C2439EDC-A9AA-4234-AAAF-5EC02412E2A9Q33151151-B66A12F8-C9B8-4885-86ED-6C135CC9457FQ33248218-1D9D8EE0-9AE8-43CA-999E-F4039B49C3FCQ33402456-F8B81C11-862A-46E8-A60F-043F637B6C08Q33529321-71E77F8C-0CF8-4D4B-97CF-FE1E41369F21Q33724257-4F6BA840-CE98-4F1B-A54E-752E2002D97DQ33737805-DCC0E716-19DB-4F6E-9238-5E2E3DF476E6Q33983707-B4FAED96-76B7-4E3B-B2D5-16CE4752C508Q34025450-77F47443-87FE-4393-814E-2F54A37BFBBCQ34105006-2BDF498B-9BEF-4EED-AFE0-9EDC694F79FDQ34109912-BE032FE4-FC51-4885-A735-8601B3F16143Q34161634-5C8F65D2-8E81-4F9F-8BD5-55753011C651Q34217598-059F2C12-40D7-4D53-8690-F80B375E17D4Q34360563-1EDE95F5-2699-44D5-9246-7CFEE2CD29BAQ34498274-9604E6DD-65D7-41A8-A98E-4CBC1207E3D4Q34498279-CFCAF9F0-7FAA-44F2-B81A-5144145D46A2Q34523145-47FFCD86-BBB4-4135-B875-5359030205D7Q34526493-BA594CFB-0938-4DD2-9392-21B94048B659Q34554855-709D88F5-800A-417E-A19F-E75FE9AF0DE1Q34580380-7E42999C-33AF-4908-96ED-A089D31BDE57Q34596340-0A683F21-A944-4144-AA9C-EF44F108AD49Q34596349-1FDCD411-ADF3-4021-A6E1-A25F6A14B2D9Q34596404-2DC980B6-38B5-4611-8FFB-8723BE0E0C5AQ34976717-1FACBA7B-6D0D-4FBF-AC25-58A16C6C8D87Q35024591-E9E5B621-FC10-40B0-987A-C4158A36580CQ35767245-92E53D81-51E3-4CE0-9F6C-252387DD6517
P50
description
deutscher Neurologe und Hirnforscher
@de
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Günther Deuschl
@ast
Günther Deuschl
@de
Günther Deuschl
@en
Günther Deuschl
@es
Günther Deuschl
@nl
Günther Deuschl
@sl
type
label
Günther Deuschl
@ast
Günther Deuschl
@de
Günther Deuschl
@en
Günther Deuschl
@es
Günther Deuschl
@nl
Günther Deuschl
@sl
prefLabel
Günther Deuschl
@ast
Günther Deuschl
@de
Günther Deuschl
@en
Günther Deuschl
@es
Günther Deuschl
@nl
Günther Deuschl
@sl
P1006
P214
P227
P1006
P106
P21
P214
P227
P31
P569
1950-01-01T00:00:00Z
P735
P7859
lccn-n99802062